视网膜神经受体及其分子显像研究进展

刘淼; 刘兴党; 刘淼; 刘兴党

doi:10.3760/cma.j.issn.1673-4114.2017.05.010

[1]

De Melo Reis RA, Cabral-Da-Silva Me, De Mello FG, et al.Müller glia factors induce survival and neuritogenesis of peripheral and central neurons[J]. Brain Res, 2008, 1205:1-11. DOI:10.1016/j.brainres.2008.02.035.

[2]

Kubrusly RC, Panizzutti R, Gardino PF, et al. Expression of functional dopaminergic phenotype in purified cultured muller cells from vertebrate retina[J]. Neurochem Int, 2008, 53(3/4):63-70. DOI:10.1016/j.neuint.2008.05.002.

[3]

Semkova I, Huemmeke M, Ho MS, et al. Retinal localization of the glutamate receptor GluR2 and GluR2-regulating proteins in diabetic rats[J]. Exp Eye Res, 2010, 90(2):244-253. DOI:10.1016/j.exer.2009.10.012.

[4]

Gu L, Xu H, Wang F, et al. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina[J]. Invest Ophthalmol Vis Sci, 2014, 55(12):8208-8222. DOI:10.1167/iovs.14-14435.

[5]

Belforte NA, Moreno MC, De Zavalía N, et al. Melatonin:a novel neuroprotectant for the treatment of glaucoma[J]. J Pineal Res, 2010, 48(4):353-364. DOI:10.1111/j.1600-079X.2010.00762.x.

[6]

王中峰, 杨雄里.谷氨酸受体在实验性青光眼视网膜细胞损伤中的作用[J].生理学报, 2016, 68(4):483-491.
Wang ZF, Yang XL. Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma[J]. Acta Physiol Sin, 2016, 68(4):483-491.

[7]

Santiago AR, Hughes JM, Kamphuis W, et al. Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina[J]. Brain Res, 2008, 1198:153-159. DOI:10.1016/j.brainres.2007.12.030.

[8]

Fu S, Dong S, Zhu M, et al. Müller Glia are a major cellular source of survival signals for retinal neurons in diabetes[J]. Diabetes, 2015, 64(10):3554-3563. DOI:10.2337/db15-0180.

[9]

Akopian A, Kumar S, Ramakrishnan H, et al. Amacrine cells coupled to ganglion cells via gap junctions are highly vulnerable in glaucomatous mouse retinas[J/OL]. J Comp Neurol, 2016[2017-06-20]. http://onlinelibrary.wiley.com/doi/10.1002/cne.24074/abstract.[Epublished online ahead of print July 25, 2016]. DOI:10.1002/cne.24074.

[10]

Sanchez-Chavez G, Velazquez-Flores MA, Ruiz ER, et al. Glycine receptor subunits expression in the developing rat retina[J]. Neuro-chem Int, 2017, 108:177-182. DOI:10.1016/j.neuint.2017.03.013.

[11]

Zhou X, Pardue MT, Iuvone PM, et al. Dopamine signaling and myopia development:What are the key challenges[J/OL]. Prog Retin Eye Res, 2017[2017-06-20]. https://linkinghub.elsevier.com/retrieve/pii/S1350-9462(17)30010-1.DOI:10.1016/j.preteyeres.2017.06.003.

[12]

Yang JW, Xu YC, Sun L, et al. 5-hydroxytryptamine level and 5-HT2A receptor mRNA expression in the guinea pigs eyes with spectacle lens-induced myopia[J]. Int J Ophthalmol, 2010, 3(4):299-303. DOI:10.3980/j.issn.2222-3959.2010.04.05.

[13]

Wang WF, Ishiwata K, Kiyosawa M, et al. Investigation of the use of positron emission tomography for neuroreceptor imaging in rabbit eyes[J]. Ophthalmic Res, 2004, 36(5):255-263. DOI:10.1159/000081205.

[14]

Malmfors T. Evidence of adrenergic neurons with synaptic terminals in the retina of rats demonstrated with fluorescence and electron microscopy[J]. Acta Physiol Scand, 1963, 58(1):99-100. DOI:10.1111/j.1748-1716.1963.tb02632.x.

[15]

Nickla DL, Totonelly K, Dhillon B. Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks[J]. Exp Eye Res, 2010, 91(5):715-720. DOI:10.1016/j.exer.2010.08.021.

[16]

Huang F, Yan T, Shi F, et al. Activation of dopamine D2 receptor is critical for the development of form-deprivation myopia in the C57BL/6 mouse[J]. Invest Ophthalmol Vis Sci, 2014, 55(9):5537-5544. DOI:10.1167/iovs.13-13211.

[17]

Ward AH, Siegwart JT, Frost MR, et al. Intravitreally-administered dopamine D2-like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews[J/OL]. Vis Neurosci, 2017, 34:E003[2017-06-20]. https://www.cambridge.org/core/journals/visual-neuroscience/article/intravitreallyadministered-dopamine-d2like-and-d4-but-not-d1like-receptor-agonists-reduce-formdeprivation-myopia-in-tree-shrews/48D706C13ED5DB116BA32E9646D9FCD3.DOI:10.1017/S0952523816000195.

[18]

赵娟, 刘兴党.实验性近视眼视网膜多巴胺神经系统研究进展[J].国际放射医学核医学杂志, 2007, 31(2):73-76. DOI:10.3760/cma.j.issn.1673-4114.2007.02.004.
Zhao J, Liu XD. Study and development of retinal dopamine nervous system in experimental myopia[J]. Int J Radiat Med Nucl Med, 2007, 31(2):73-76. doi: 10.3760/cma.j.issn.1673-4114.2007.02.004

[19]

Lacivita E, De Giorgio P, Lee IT, et al. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors[J]. J Med Chem, 2010, 53(20):7344-7355. DOI:10.1021/jm100925m.

[20]

毛俊峰, 刘双珍, 秦文娟, 等.豚鼠形觉剥夺性近视眼视网膜, 脉络膜多巴胺代谢的变化[J].中华眼视光学与视觉科学杂志, 2009, 11(1):33-37. DOI:10.3760/cma.j.issn.1674-845X.2009.01.010.
Mao JF, Liu SZ, Qin WJ, et al. The change in dopamine metabolism in the retina and choroid of the Guinea pig with form-deprivation myopia[J]. Chin J Optom Ophthalmol Vis Sci, 2009, 11(1):33-37. doi: 10.3760/cma.j.issn.1674-845X.2009.01.010

[21]

Stone RA, Cohen Y, Mcglinn AM, et al. Development of experimental myopia in chicks in a natural environment[J]. Invest Ophthalmol Vis Sci, 2016, 57(11):4779-4789. DOI:10.1167/iovs.16-19310.

[22]

Zhao J, Qu X, Qi Y, et al. Study on retinal dopamine transporter in form deprivation myopia using the radiopharmaceutical tracer ^99mTc-TRODAT-1[J]. Nucl Med Commun, 2010, 31(10):910-915. DOI:10.1097/MNM.0b013e32833decc0.

[23]

Tuerxun T, Numakawa T, Adachi N, et al. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stressinduced cell death via suppression of MAPK pathway activation and glutamate receptor expression[J]. Neurosci Lett, 2010, 469(3):303-308. DOI:10.1016/j.neulet.2009.12.013.

[24]

Chien CC, Pasternak GW. Selective antagonism of opioid analgesia by a sigma system[J]. J Pharmacol Exp Ther, 1994, 271(3):1583-1590.

[25]

Ramakrishnan NK, Visser AK, Schepers M, et al. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with ¹¹C-SA4503 and microPET[J]. Psychopharmacology(Berl), 2014, 231(20):3997-4006. DOI:10.1007/s00213-014-3533-2.

[26]

Liu LL, Wang L, Zhong YM, et al. Expression of sigma receptor 1 mRNA and protein in rat retina[J]. Neuroscience, 2010, 167(4):1151-1159. DOI:10.1016/j.neuroscience.2010.03.006.

[27]

Tagashira H, Zhang C, Lu YM, et al. Stimulation of sigma-1 receptor restores abnormal mitochondrial Ca2+ mobilization and ATP production following cardiac hypertrophy[J]. Biochim Biophys Acta, 2013, 1830(4):3082-3094. DOI:10.1016/j.bbagen.2012.12.029.

[28]

Shimazawa M, Sugitani S, Inoue Y, et al. Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage[J]. Exp Eye Res, 2015, 132:64-72. DOI:10.1016/j.exer.2015.01.017.

[29]

Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines[J]. Cancer Res, 1995, 55(2):408-413.

[30]

Wang WF, Ishiwata K, Kiyosawa M, et al. Visualization of sigma1 receptors in eyes by ex vivo autoradiography and in vivo positron emission tomography[J]. Exp Eye Res, 2002, 75(6):723-730. doi: 10.1006/exer.2002.2048

[31]

Bor-Seng-Shu E, Felicio AC, Braga-Neto P, et al. Dopamine transporter imaging using ^99mTc-TRODAT-1 SPECT in Parkinson's disease[J]. Med Sci Monit, 2014, 20:1413-1418. DOI:10.12659/MSM.890522.

[32]

Shimizu S, Hirao K, Kanetaka H, et al. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease[J]. Eur J Nucl Med Mol Imaging, 2016, 43(1):184-192. DOI:10.1007/s00259-015-3146-y.

[33]

Wu H, Lou C, Huang Z, et al. SPECT imaging of dopamine transporters with ^99mTc-TRODAT-1 in major depression and Parkinson's disease[J]. J Neuropsychiatry Clin Neurosci, 2011, 23(1):63-67. DOI:10.1176/jnp.23.1.jnp63.

[34]

Yuan J, Liu XD, Han M, et al. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects[J]. Addict Biol, 2015, 22(1):229-234. DOI:10.1111/adb.12271.

[35]

Yuan J, Lv R, Robert Brašić J, et al. Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence[J]. Psychiatry Res, 2014, 221(1):92-96. DOI:10.1016/j.pscychresns.2013.11.005.

[36]

Liu Y, Han M, Liu X, et al. Dopamine transporter availability in heroin-dependent subjects and controls:longitudinal changes during abstinence and the effects of Jitai tablets treatment[J]. Psychopharmacology(Berl), 2013, 230(2):235-244. DOI:10.1007/s00213-013-3148-z.

[37]

席晓勍, 褚仁远, 周行涛, 等.实验性近视眼视网膜多巴胺转运蛋白研究[J].中华眼科杂志, 2003, 39(6):27-30. DOI:10.3760/j:issn:0412-4081.2003.06.007.
Xi XQ, Chu RY, Zhou HT, et al. Studies of retinal dopamine transporter in experimental myopia[J]. Chin J Ophthalmol, 2003, 39(6):27-30. doi: 10.3760/j:issn:0412-4081.2003.06.007

[38]

汪维芳, 盛敏杰, 林安娟, 等.正电子发射断层扫描术在兔眼神经受体成像的应用[J].眼科新进展, 2009, 29(7):514-518.
Wang WF, Sheng MJ, Lin AJ, et al. Application of positron emission tomography for imaging of neuroreceptor in rabbit eyes[J]. Rec Adv Ophthal, 2009, 29(7):514-518.

[39]

汪维芳, 盛敏杰, 林安娟, 等.眼内σ1受体在PET中显像的实验研究[J].眼科, 2009, 18(3):198-203.
Wang WF, Sheng MJ, Lin AJ, et al. Visualization of σ1 receptors in eyes by in vivo positron emission tomography and ex vivo autoradiography[J]. Ophthalmol Chn, 2009, 18(3):198-203.